Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.
Autophagy and autoimmunity crosstalks.
Multiple neurological abnormalities, including pontine hemorrhage, multiple sclerosis and aseptic meningitis, during anti-TNF-α therapy in psoriatic arthritis.
Proteome analysis of spinal cord during the clinical course of monophasic experimental autoimmune encephalomyelitis.
Could behavioral therapies target specific deficits in multiple sclerosis patients?
Clinical Improvement after Extracranial Venoplasty in Multiple Sclerosis.
The Evaluation of the Retinal Nerve Fiber Layer in Multiple Sclerosis with Special-Domain Optical Coherence Tomography.
Concurrent Quantification of Tryptophan and Its Major Metabolites.
Heavy-light chain interrelations of MS-associated immunoglobulins probed by deep sequencing and rational variation.
Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis.
Mitochondrial dysfunction in central nervous system white matter disorders.
Update on neurodegeneration with brain iron accumulation.
Apitope starts new clinical trial of its investigational Multiple Sclerosis treatment
Italian validation of the 12-item multiple sclerosis walking scale.
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.
Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors.
Association of interleukin-1 gene polymorphisms with multiple sclerosis: a meta-analysis.
Mast cells and inflammation.
Imaging of glutamate in the spinal cord using GluCEST.
Metabolite changes in radiologically isolated syndrome: More pathology than meets the eye?
A microbial symbiosis factor prevents intestinal inflammatory disease.
[Spasticity and everyday life in multiple sclerosis].
[Ginkgolide B promotes axonal growth of retina ganglion cells by anti-apoptosis in vitro].
Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.
Mortality and Cause of Death in Multiple Sclerosis: Findings from a Prospective Population-Based Cohort in Bizkaia, Basque Country, Spain.

Pages